Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

Podcasts

Podcasts
A Payer's Perspective on Value-Based Care and Treatment Costs for Rheumatic Conditions
11/06/2023
Dr Steven Peskin, general internal medicine specialist and CEO of SRP Advisors, joins us today to discuss value-based care and treatment costs for patients with rheumatic conditions.
Dr Steven Peskin, general internal medicine specialist and CEO of SRP Advisors, joins us today to discuss value-based care and treatment costs for patients with rheumatic conditions.
Dr Steven Peskin, general...
11/06/2023
First Report Managed Care
Headshot of Derek Streat on a blue background underneath the PopHealth Perspectives logo.
Podcasts
Problems and Innovations in Streamlining Virtual Care Services
09/29/2023
Derek Streat, Co-Founder, CEO, and Chairman of DexCare, joins us today to learn about how DexCare technology’s Get Care Now program in partnership with UR Medicine is finding ways to virtually connect patients with providers faster.
Derek Streat, Co-Founder, CEO, and Chairman of DexCare, joins us today to learn about how DexCare technology’s Get Care Now program in partnership with UR Medicine is finding ways to virtually connect patients with providers faster.
Derek Streat, Co-Founder, CEO,...
09/29/2023
Integrated Healthcare Executive
Headshot of Anthony Watson on a blue background underneath the PopHealth Perspectives logo.
Podcasts
Payer Reimbursement and Prescription Digital Therapeutics: Understanding FDA Regulations
06/29/2023
Anthony Watson, former vice president of Regulatory and Quality at Pear Therapeutics, discusses his recent perspective article explaining FDA regulations as they relate to prescription digital therapeutics (PDTs) and highlights why he...
Anthony Watson, former vice president of Regulatory and Quality at Pear Therapeutics, discusses his recent perspective article explaining FDA regulations as they relate to prescription digital therapeutics (PDTs) and highlights why he...
Anthony Watson, former vice...
06/29/2023
First Report Managed Care

Advertisement

Headshot of Rimal Bera, UC Irvine, on a blue background underneath the PopHealth Perspectives logo.
Podcasts
Selecting Atypical Antipsychotics for Patients With Bipolar Disorder
06/20/2023
Rimal Bera, MD, clinical professor of psychiatry, University of California, Irvine, breaks down major factors in selecting antipsychotics for bipolar disorder and the importance of treatments with high adherence rates.
Rimal Bera, MD, clinical professor of psychiatry, University of California, Irvine, breaks down major factors in selecting antipsychotics for bipolar disorder and the importance of treatments with high adherence rates.
Rimal Bera, MD, clinical...
06/20/2023
Veterans Health Today
Headshot of Clement Chung, Houston Methodist, on a blue background underneath the PopHealth Perspectives logo.
Podcasts
Considerations for Selecting Small Molecule Inhibitors for Patients With CLL
05/26/2023
Clement Chung, PharmD, MS, BCOP, BCPS, senior clinical pharmacy specialist, hematology and oncology, Houston Methodist West Hospital, reviews the landscape of small molecule inhibitors for chronic lymphocytic leukemia, including important...
Clement Chung, PharmD, MS, BCOP, BCPS, senior clinical pharmacy specialist, hematology and oncology, Houston Methodist West Hospital, reviews the landscape of small molecule inhibitors for chronic lymphocytic leukemia, including important...
Clement Chung, PharmD, MS, BCOP,...
05/26/2023
First Report Managed Care
Headshot of Russell Spjut on a blue background underneath the PopHealth Perspectives logo.
Podcasts
Understanding Regulatory Pathways for Prescription Digital Therapeutics From a PBM, Payer Perspective
03/30/2023
Russell Spjut, PharmD, director, formulary management, Magellan Rx Management, shares insight on the regulatory pathways for emerging PDTs, and discusses some of the work of the Digital Therapeutic Alliance.
Russell Spjut, PharmD, director, formulary management, Magellan Rx Management, shares insight on the regulatory pathways for emerging PDTs, and discusses some of the work of the Digital Therapeutic Alliance.
Russell Spjut, PharmD, director,...
03/30/2023
First Report Managed Care

Advertisement

Russell Spjut
Podcasts
PDTs vs DTx: What’s the Difference?
03/21/2023
Russell Spjut, PharmD, director, formulary management, Magellan Rx Management, offers some insight on the difference between digital therapeutics terminology and the current landscape for these products.
Russell Spjut, PharmD, director, formulary management, Magellan Rx Management, offers some insight on the difference between digital therapeutics terminology and the current landscape for these products.
Russell Spjut, PharmD, director,...
03/21/2023
First Report Managed Care
Headshot of John Tesser, MD, on a blue background underneath the PopHealth Perspectives logo.
Podcasts
Combining Pegloticase With Methotrexate Bolsters Response Rate in Patients With Chronic Gout
03/02/2023
John RP Tesser, MD, rheumatology specialist, Arizona Arthritis & Rheumatology Associates, and clinical adjunct professor, Midwestern University College of Health Sciences, discusses the MIRROR trial, a study which showed the addition of an...
John RP Tesser, MD, rheumatology specialist, Arizona Arthritis & Rheumatology Associates, and clinical adjunct professor, Midwestern University College of Health Sciences, discusses the MIRROR trial, a study which showed the addition of an...
John RP Tesser, MD, rheumatology...
03/02/2023
First Report Managed Care

Advertisement

Craig Gravina, chief technology officer, ObvioHealth
Podcasts
Navigating the Path to Approval for PDTs Using Decentralized Clinical Trials
02/27/2023
Craig Gravina, chief technology officer, ObvioHealth, sheds some light on the current digital therapeutics landscape, including regulatory challenges, the prescription DTx model, and solutions to improve clinical trial research.
Craig Gravina, chief technology officer, ObvioHealth, sheds some light on the current digital therapeutics landscape, including regulatory challenges, the prescription DTx model, and solutions to improve clinical trial research.
Craig Gravina, chief technology...
02/27/2023
First Report Managed Care

Advertisement

Advertisement

Advertisement

What's Trending?

Diagnosing Sarcoidosis: Endosonography versus Bronchoscopy
08/14/2013
The incidence of sarcoidosis, a multisystem granulomatous disease of unclear etiology, is, according to researchers, high, with up to 40 cases per 100,000 individuals. In addition, mortality related to sarcoidosis is increasing. The disease...
The incidence of sarcoidosis, a multisystem granulomatous disease of unclear etiology, is, according to researchers, high, with up to 40 cases per 100,000 individuals. In addition, mortality related to sarcoidosis is increasing. The disease...
The incidence of sarcoidosis, a...
08/14/2013
First Report Managed Care
News
Students Welcomed to Live in Nursing Facilities
02/14/2017
Some nursing homes are allowing college students to move into their facilities under mutually beneficial terms.
Some nursing homes are allowing college students to move into their facilities under mutually beneficial terms.
Some nursing homes are allowing...
02/14/2017
Annals of Long-Term Care
News
FDA Panel Votes Against Approval of GSK Lung Disease Drug
07/25/2018
An expert panel for the FDA did not support the approval of a drug intended for the treatment of COPD.
An expert panel for the FDA did not support the approval of a drug intended for the treatment of COPD.
An expert panel for the FDA did...
07/25/2018
Pharmacy Learning Network
News
Safety and Efficacy of Topical Diclofenac Sodium 1% Gel in Seniors and Younger Patients with Hand Osteoarthritis
03/04/2015
Results, presented at the annual AAPM meeting, revealed that DSG was effective and generally well tolerated for hand OA, regardless of patient age.
Results, presented at the annual AAPM meeting, revealed that DSG was effective and generally well tolerated for hand OA, regardless of patient age.
Results, presented at the annual...
03/04/2015
Annals of Long-Term Care
News
Test Designed to Screen Resistance to Cancer Drug
07/29/2010
07/29/2010
First Report Managed Care

Advertisement

Stay Informed—Sign up today!

Population Health Newsletter

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use